Absence of copy number gain of <i>EGFR</i> : A possible predictive marker of long‐term response to afatinib-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Absence of copy number gain of EGFR : A possible predictive marker of long‐term response to afatinib

Published:2022-12-16 Issue:3 Volume:114 Page:1045-1055
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Science

Author:

Nakamura Tomomi¹^ORCID,Sato Akemi²^ORCID,Nakashima Chiho¹,Abe Tomonori¹,Iwanaga Kentaro³,Umeguchi Hitomi⁴,Kawaguchi Atsushi⁵,Sueoka‐Aragane Naoko¹

Affiliation:

1. Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine Saga University Saga Japan

2. Department of Clinical Laboratory Medicine, Faculty of Medicine Saga University Saga Japan

3. Division of Respiratory Medicine Saga‐Ken Medical Centre Koseikan Saga Japan

4. Department of Respiratory Medicine Karatsu Red Cross Hospital Saga Japan

5. Education and Research Center for Community Medicine, Faculty of Medicine Saga University Saga Japan

Funder

Boehringer Ingelheim

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.15655

Reference51 articles.

1. A Noninvasive System for Monitoring Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors with Plasma DNA

2. Application of a Highly Sensitive Detection System for Epidermal Growth Factor Receptor Mutations in Plasma DNA

3. Profile of the Roche cobas® EGFR mutation test v2 for non-small cell lung cancer

4. Noninvasive Detection of Response and Resistance in EGFR-Mutant Lung Cancer Using Quantitative Next-Generation Genotyping of Cell-Free Plasma DNA

5. Circulating mutant DNA to assess tumor dynamics

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The cell line models to study tyrosine kinase inhibitors in non-small cell lung cancer with mutations in the epidermal growth factor receptor: A scoping review;Critical Reviews in Oncology/Hematology;2024-02

2. Genomic characterisation of de novo EGFR copy number gain and its impact on the efficacy of first-line EGFR-tyrosine kinase inhibitors for EGFR mutated non-small cell lung cancer;European Journal of Cancer;2023-07

3. Clinical application of liquid biopsy based on circulating tumor DNA in non-small cell lung cancer;Frontiers in Physiology;2023-06-07

4. Complete response to first-line osimertinib monotherapy in a complex epidermal growth factor receptor mutant (L833V/H835L) lung adenocarcinoma patient: a case report;Anti-Cancer Drugs;2023-04-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3